Yingsheng Biology

company

About

Yingsheng Biology is a human genetic and molecular diagnostic technology developer.

  • 251 - 500

Details

Last Funding Type
Series C
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2009
Number Of Employee
251 - 500
Operating Status
Active

Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product line includes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
Yingsheng Biology has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 29, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2022 Series C 3 Detail
Nov 12, 2020 Series B 1 Detail
Jul 21, 2018 Series A 2 Detail

Investors

Number of Lead Investors
Number of Investors
6
Yingsheng Biology is funded by 6 investors. Huiyi Xinxi and Jingming Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Huiyi Xinxi Series C
Jingming Capital Series C
Sunz Fund Series C
Ronghui Capital Series B
Source Capital Series A
Yahui Precision Medicine Fund Series A